| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/27/2011 | US20110020790 Use of regulatory sequences for specific, transient expression in neuronal determined cells |
| 01/27/2011 | US20110020784 Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation |
| 01/27/2011 | US20110020526 Corn plants and seed enhanced for asparagine and protein |
| 01/27/2011 | US20110020437 Oligopeptidic compounds and uses thereof |
| 01/27/2011 | US20110020403 immunizing composition |
| 01/27/2011 | US20110020402 Method For Identification, Isolation And Production Of Antigens To A Specific Pathogen |
| 01/27/2011 | US20110020399 Vaccines and Immunomodulatory Therapies for Tularemia |
| 01/27/2011 | US20110020398 Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus |
| 01/27/2011 | US20110020394 Pcv2 orf2 virus like particle with foreign amino acid insertion |
| 01/27/2011 | US20110020390 Meningococcal fhbp polypeptides |
| 01/27/2011 | US20110020387 Malaria vaccine |
| 01/27/2011 | US20110020383 Novel genes and proteins of brachyspira hyodysenteriae and uses thereof |
| 01/27/2011 | US20110020375 Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use |
| 01/27/2011 | US20110020374 Expression system for modulating an immune response |
| 01/27/2011 | US20110020373 Ige directed dna vaccination |
| 01/27/2011 | US20110020372 Follistatin domain containing proteins |
| 01/27/2011 | US20110020369 Engineered anti-tslpr antibodies |
| 01/27/2011 | US20110020368 Treating cancer by down-regulating frizzled-4 and/or frizzled-1 |
| 01/27/2011 | US20110020361 Human anti-mesothelin monoclonal antibodies |
| 01/27/2011 | US20110020360 Targeted binding agents directed to pdgrf-alpha and uses thereof |
| 01/27/2011 | US20110020357 Anti human immunodeficiency antibodies and uses thereof |
| 01/27/2011 | US20110020354 G-protein coupled receptor ligands and methods |
| 01/27/2011 | US20110020352 Endogenous retroviruses up-regulated in prostate cancer |
| 01/27/2011 | US20110020351 Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 01/27/2011 | US20110020349 Anti-factor xi monoclonal antibodies and methods of use thereof |
| 01/27/2011 | US20110020346 Anti-vegf antibodies |
| 01/27/2011 | US20110020345 Drug fusions and conjugates |
| 01/27/2011 | US20110020344 Human monoclonal antibodies specific for cd22 |
| 01/27/2011 | US20110020342 Igf-1 fusion polypeptides and therapeutic uses thereof |
| 01/27/2011 | US20110020330 Antibody inhibitors of gdf-8 and uses thereof |
| 01/27/2011 | US20110020321 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/27/2011 | US20110020314 Identifying haematopoietic stem cells based on cell surface markers |
| 01/27/2011 | US20110020309 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergice disease |
| 01/27/2011 | US20110020308 Expression of transgenic t cell receptors in lak-t cells |
| 01/27/2011 | US20110020306 Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof |
| 01/27/2011 | US20110020305 Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof |
| 01/27/2011 | US20110020300 Compositions and methods for inhibiting expression of glucocorticoid receptor (gcr) genes |
| 01/27/2011 | US20110020288 Reoviruses Having Modified Sequences |
| 01/27/2011 | US20110020267 Tweak receptor |
| 01/27/2011 | US20110020266 G-CSF Conjugates |
| 01/27/2011 | US20110020234 Rna interference mediating small rna molecules |
| 01/27/2011 | US20110020229 Multi-Component Biological Transport Systems |
| 01/27/2011 | US20110020226 Particle structures comprising sterols and saponins |
| 01/27/2011 | US20110020223 Polypeptides having affinity for her2 |
| 01/27/2011 | US20110020222 Modified antibodies and methods of use |
| 01/27/2011 | US20110020220 Humanized antibodies against the beta-amyloid peptide |
| 01/27/2011 | US20110020219 Anti-human tenascin monoclonal antibody |
| 01/27/2011 | US20110020218 Novel anti cxcr4 antibodies and their use for the treatment of cancer |
| 01/27/2011 | CA2768947A1 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
| 01/27/2011 | CA2768938A1 Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein |
| 01/27/2011 | CA2768897A1 Fermentative glycerol-free ethanol production |
| 01/27/2011 | CA2768699A1 Method and kit for detection of live microorganisms |
| 01/27/2011 | CA2768608A1 Improved host cell for the production of a compound of interest |
| 01/27/2011 | CA2768571A1 The use of dimerization domain component stacks to modulate plant architecture |
| 01/27/2011 | CA2768502A1 Sugarcane centromere sequences and minichromosomes |
| 01/27/2011 | CA2768331A1 Plants with increased yield |
| 01/27/2011 | CA2768125A1 Plastid transit peptides derived from lower photosynthetic eukaryotes and methods |
| 01/27/2011 | CA2768042A1 Raf dimers and uses thereof |
| 01/27/2011 | CA2767724A1 Sorghum centromere sequences and minichromosomes |
| 01/27/2011 | CA2767377A1 Method for genome editing |
| 01/27/2011 | CA2765313A1 Methods and compositions for improving sugar transport, mixed sugar fermentation, and production of biofuels |
| 01/26/2011 | EP2278509A1 Methods, systems, and software for identifying functional biomolecules |
| 01/26/2011 | EP2278317A1 Field effect transistor device for ultra-fast nucleic acid sequencing |
| 01/26/2011 | EP2278028A1 Method for diagnosing non-small cell lung cancers |
| 01/26/2011 | EP2278024A1 Epitope cluster from NY-ESO-1 for the induction of anti-tumor immunogenicity |
| 01/26/2011 | EP2278023A1 Epitope cluster from Melan-A/MART-1 for the induction of anti-tumor immunogenicity |
| 01/26/2011 | EP2278022A2 Expression vectors, transfection systems, and method of use thereof |
| 01/26/2011 | EP2278021A2 Expression vectors, transfection systems, and method of use thereof |
| 01/26/2011 | EP2278020A2 Antibody gene transfer and recombinant AAV therefor |
| 01/26/2011 | EP2278019A1 Nucleotide sequences mediating plant male fertility and method of using same |
| 01/26/2011 | EP2278018A2 Nucleic acid sequences encoding proteins associated with abiotic stress response |
| 01/26/2011 | EP2278017A1 A method of selectively producing male or female sterile plants |
| 01/26/2011 | EP2278016A1 Promoter sequences derived from Fusarium Venenatum and uses thereof |
| 01/26/2011 | EP2278015A1 Method of producing a carbohydrate ester |
| 01/26/2011 | EP2278014A2 Method for producing alcohol and carboxylic acid having optical activity |
| 01/26/2011 | EP2278013A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2278012A2 Avirulent, immunogenic flavivirus chimeras |
| 01/26/2011 | EP2278011A2 Neisseria meningitidis antigens |
| 01/26/2011 | EP2278010A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278009A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278008A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/26/2011 | EP2278007A1 Conserved neisserial antigens |
| 01/26/2011 | EP2278006A2 Neisserial antigens |
| 01/26/2011 | EP2278005A2 Fuctional and hyperfunctional sirna |
| 01/26/2011 | EP2278004A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 01/26/2011 | EP2278003A2 Method for controlling the activity of immunologically functional molecule |
| 01/26/2011 | EP2278001A1 Protease variants and compositions |
| 01/26/2011 | EP2277998A1 Urate oxidase |
| 01/26/2011 | EP2277997A2 Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same |
| 01/26/2011 | EP2277996A2 Methods for producing preparations of recombinant AAV virions substantially free of empty capsids |
| 01/26/2011 | EP2277995A1 Method for preparation of platelet from ips cell |
| 01/26/2011 | EP2277989A1 Fermentative glycerol-free ethanol production |
| 01/26/2011 | EP2277920A2 Inhibitors of complement activation |
| 01/26/2011 | EP2277919A1 Treatment with anti-ERBB2 antibodies |
| 01/26/2011 | EP2277917A2 B7-H3L cell surface target and a family of antibodies recognizing that target |
| 01/26/2011 | EP2277914A2 Antigen binding domains from fish |
| 01/26/2011 | EP2277913A2 Antigen binding domains from fish |
| 01/26/2011 | EP2277910A1 Albumin fusion proteins |
| 01/26/2011 | EP2277908A2 IL-17A/F heterologous polypeptides, antibodies and therapeutic uses thereof |
| 01/26/2011 | EP2277907A2 Differential in tumour gene products and use of same |